(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

ST13

US500000076427104

Class

5

Filing

76427104

Registration

2952351

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

58

Latest update

11/16/2025

Trademark type

Combined

Nice classes

5

Filing date

07/02/2002

Registration date

05/17/2005

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/15/2025

Last transaction

11/16/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/07/2002

First use in commerce

10/07/2002

Drawing code

3

Owner type

03

Owner location

Palo Alto, CA

Examiner

CASE,LEIGH CAROLINE

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

JAZZ PHARMACEUTICALS, INC.
JPI Commercial, LLC
Orphan Medical, Inc.

Representatives

Michael Olsen Winthrop & Weinstine, P.A.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for use in the treatment of sleep disorders

Publications

History of USPTO decisions and trademark events.

58 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/11/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/11/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/11/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/11/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/11/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/15/2025

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

09/15/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/15/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/15/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

05/16/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/17/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/26/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/15/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/15/2019

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/23/2018

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/23/2018

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

07/27/2016

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/09/2016

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

07/22/2015

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/10/2015

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/10/2015

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/10/2015

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

03/27/2015

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

11/29/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/29/2014

E89R

TEAS SECTION 8 & 9 RECEIVED

11/10/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/08/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/06/2010

E815

TEAS SECTION 8 & 15 RECEIVED

11/17/2010

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/24/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

05/17/2005

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

03/30/2005

ALIE

ASSIGNED TO LIE

03/25/2005

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/18/2005

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/18/2005

DOCK

ASSIGNED TO EXAMINER

08/11/2004

CFIT

CASE FILE IN TICRS

07/26/2004

IUAF

USE AMENDMENT FILED

07/15/2004

EX3G

SOU EXTENSION 3 GRANTED

07/15/2004

EXT3

SOU EXTENSION 3 FILED

07/15/2004

EISU

TEAS STATEMENT OF USE RECEIVED

07/15/2004

EEXT

SOU TEAS EXTENSION RECEIVED

07/15/2004

EX2G

SOU EXTENSION 2 GRANTED

04/01/2004

EXT2

SOU EXTENSION 2 FILED

03/24/2004

EEXT

SOU TEAS EXTENSION RECEIVED

03/24/2004

MAIL

PAPER RECEIVED

11/10/2003

MAIL

PAPER RECEIVED

10/14/2003

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/07/2003

EX1G

SOU EXTENSION 1 GRANTED

10/03/2003

EXT1

SOU EXTENSION 1 FILED

09/25/2003

EEXT

SOU TEAS EXTENSION RECEIVED

09/25/2003

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

03/25/2003

PUBO

PUBLISHED FOR OPPOSITION

12/31/2002

NPUB

NOTICE OF PUBLICATION

12/11/2002

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/11/2002

CNRT

NON-FINAL ACTION MAILED

10/07/2002

DOCK

ASSIGNED TO EXAMINER

10/01/2002

DOCK

ASSIGNED TO EXAMINER

09/25/2002

Continuous trademark protection

Get notified about every new filing that threatens XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.